DE60013425D1 - Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken - Google Patents

Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken

Info

Publication number
DE60013425D1
DE60013425D1 DE60013425T DE60013425T DE60013425D1 DE 60013425 D1 DE60013425 D1 DE 60013425D1 DE 60013425 T DE60013425 T DE 60013425T DE 60013425 T DE60013425 T DE 60013425T DE 60013425 D1 DE60013425 D1 DE 60013425D1
Authority
DE
Germany
Prior art keywords
composition
active ingredient
aerosol formation
medical compositions
inhalation purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60013425T
Other languages
English (en)
Other versions
DE60013425T2 (de
Inventor
M Thurston
D Browning
K Shah
E Placke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Memorial Institute Inc
Original Assignee
Battelle Memorial Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Memorial Institute Inc filed Critical Battelle Memorial Institute Inc
Application granted granted Critical
Publication of DE60013425D1 publication Critical patent/DE60013425D1/de
Publication of DE60013425T2 publication Critical patent/DE60013425T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
    • B05B5/025—Discharge apparatus, e.g. electrostatic spray guns
    • B05B5/0255—Discharge apparatus, e.g. electrostatic spray guns spraying and depositing by electrostatic forces only

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60013425T 1999-05-03 2000-05-02 Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken Expired - Lifetime DE60013425T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13221599P 1999-05-03 1999-05-03
US132215P 1999-05-03
PCT/US2000/011799 WO2000066206A2 (en) 1999-05-03 2000-05-02 Compositions for aerosolization and inhalation

Publications (2)

Publication Number Publication Date
DE60013425D1 true DE60013425D1 (de) 2004-10-07
DE60013425T2 DE60013425T2 (de) 2005-09-08

Family

ID=22453000

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60013425T Expired - Lifetime DE60013425T2 (de) 1999-05-03 2000-05-02 Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken

Country Status (11)

Country Link
US (1) US6503481B1 (de)
EP (1) EP1173245B1 (de)
JP (1) JP2002543165A (de)
AT (1) ATE274955T1 (de)
AU (1) AU4979700A (de)
BR (1) BR0010262A (de)
CA (1) CA2370853C (de)
DE (1) DE60013425T2 (de)
ES (1) ES2226843T3 (de)
MX (1) MXPA01011283A (de)
WO (1) WO2000066206A2 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345010B (en) * 1998-12-17 2002-12-31 Electrosols Ltd A delivery device
AU2001226029A1 (en) * 2000-01-10 2001-07-24 Dura Pharmaceuticals, Inc. Pharmaceutical formulation and method for pulmonary and oral delivery
JP2003523330A (ja) * 2000-02-04 2003-08-05 チルドレンズ・ホスピタル・リサーチ・ファウンデイション アテローム性動脈硬化症および関連疾患のための脂質加水分解治療
CA2405169C (en) * 2000-04-03 2011-07-26 Battelle Memorial Institute Devices and formulations
EP1343521A2 (de) * 2000-12-01 2003-09-17 Battelle Memorial Institute Verfahren zur stabilisierung von biomolekülen (z.b. insulin) in flüssigen formulierungen
JP2005501810A (ja) * 2001-03-22 2005-01-20 バテル メモリアル インスティチュート ポリマーおよび懸濁粒子を含有する電気流体力学的噴霧用の液体形成物
DE60230035D1 (de) 2001-05-24 2009-01-08 Alexza Pharmaceuticals Inc Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US6759029B2 (en) 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
CA2465860A1 (en) 2001-11-02 2004-04-22 Insert Therapeutics, Inc. Methods and compositions for therapeutic use of rna interference
WO2003041693A1 (en) 2001-11-09 2003-05-22 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
MXPA04004726A (es) * 2001-11-19 2004-07-30 Becton Dickinson Co Composiciones farmaceuticas en forma particulada.
DE60330805D1 (de) 2002-10-25 2010-02-11 Battelle Memorial Institute Verfahren zur nichttherapeutischen behandlung von nichtmenschlichen tieren
US7849850B2 (en) * 2003-02-28 2010-12-14 Battelle Memorial Institute Nozzle for handheld pulmonary aerosol delivery device
US20040187864A1 (en) * 2003-03-24 2004-09-30 Cindet, Llc Inhalation device and method
EP1625335A2 (de) 2003-05-21 2006-02-15 Alexza Pharmaceuticals, Inc. Optisch oder elektrisch gezündete unabhängige heizeinheit und diese einsetzende arzneimittelzufuhreinheit
FR2855069B1 (fr) * 2003-05-22 2006-06-16 Solvay Procede pour la separation d'au moins un compose organique
PT1767219E (pt) * 2004-03-10 2010-02-15 Shimoda Biotech Pty Ltd Composições injectáveis estáveis de diclofenac
KR20050099311A (ko) * 2004-04-09 2005-10-13 에이엔에이치 케어연구소(주) 주사제용 항암제 조성물
CA2562585A1 (en) 2004-04-23 2005-11-10 Cydex, Inc. Dpi formulation containing sulfoalkyl ether cyclodextrin
AU2005247410A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
US20080259519A1 (en) * 2004-09-14 2008-10-23 Battelle Memorial Institute Highly-Aqueous, Non-Respirable Aerosols Containing Biologically-Active Ingredients, Method of Making, and Device Therefor
PL1866414T3 (pl) 2005-03-31 2012-10-31 Calando Pharmaceuticals Inc Inhibitory podjednostki 2 reduktazy rybonukleotydowej i ich zastosowania
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
EP1906922A2 (de) * 2005-05-18 2008-04-09 Pulmatrix, Inc. Formulierungen zur veränderung biophysikalischer eigenschaften der schleimhautauskleidung
US20090297496A1 (en) * 2005-09-08 2009-12-03 Childrens Hospital Medical Center Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
BRPI0618214A2 (pt) 2005-11-01 2011-08-23 Alnylam Pharmaceuticals Inc inibição de rnai de replicação do influenza vìrus
WO2007083164A2 (en) * 2006-01-17 2007-07-26 Aerstream Technology Limited Liquid electrostatic spray composition
AU2006338191B2 (en) 2006-02-14 2011-06-30 Battelle Memorial Institute Dissociated discharge EHD sprayer with electric field shield
EP1993611A4 (de) 2006-03-16 2013-05-22 Alnylam Pharmaceuticals Inc Rnai-modulation von tgf-beta und ihre therapeutische verwendung
JP2007254421A (ja) * 2006-03-24 2007-10-04 Canon Inc 吐出用液体、吐出方法、吐出用カートリッジ、吐出装置及び吐出用液体の液滴化方法
CN101489566B (zh) 2006-05-19 2012-04-18 阿尔尼拉姆医药品有限公司 Aha基因的RNAi调控及其治疗性应用
US20090054333A1 (en) * 2006-10-17 2009-02-26 Antonio Giordano Peptide inhibitors of cyclin-dependent kinase activity and uses thereof
EP2117507A2 (de) * 2007-02-01 2009-11-18 Battelle Memorial Institute Zusammensetzungen zur aerosolisierung hoch leitfähiger lösungen
US20080299182A1 (en) * 2007-03-01 2008-12-04 Shuyuan Zhang Methods and formulations for topical gene therapy
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
HUE028653T2 (en) 2008-03-17 2016-12-28 Discovery Lab Inc Respiratory circuit adapter and direct aerosol delivery system
CN102037123A (zh) 2008-04-04 2011-04-27 卡兰多制药股份有限公司 Epas1抑制剂的组合物和用途
CA2683353C (en) 2008-10-22 2015-12-15 Trudell Medical International Modular aerosol delivery system
WO2010137349A1 (ja) 2009-05-29 2010-12-02 住友化学株式会社 神経栄養因子の活性が関与する疾患の治療または予防剤
US20110174304A1 (en) 2010-01-21 2011-07-21 Triplett Ii Michael D Electrohydrodynamic aerosolization device having a time varying voltage
US20120048963A1 (en) 2010-08-26 2012-03-01 Alexza Pharmaceuticals, Inc. Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter
AU2011296343B2 (en) 2010-08-30 2015-12-10 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
WO2012030647A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
CA2812414C (en) 2010-09-29 2020-09-22 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
WO2012050945A1 (en) 2010-09-29 2012-04-19 Pulmatrix, Inc. Cationic dry powders
BR112013018746B1 (pt) * 2010-12-28 2019-03-19 Sumitomo Chemical Company, Limited Método de tratamento do espaço-alvo
AU2011265562A1 (en) 2011-01-12 2012-07-26 Sumitomo Chemical Company, Limited Method of controlling harmful arthropod, composition, and electrostatic spray device
US20120302954A1 (en) * 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
JP2013070767A (ja) * 2011-09-27 2013-04-22 Panasonic Corp 機能性微粒子放出装置
SG10201604104PA (en) 2011-10-25 2016-07-28 Prothena Therapeutics Ltd Antibody formulations and methods
CN104487075A (zh) 2012-02-29 2015-04-01 普马特里克斯公司 可吸入干粉剂
MX2015013845A (es) 2013-04-01 2016-05-09 Pulmatrix Inc Polvos secos de tiotropio.
US9802010B2 (en) * 2013-11-22 2017-10-31 Noveome Biotherapeutics, Inc. Interproximal drug delivery device
EP3725311A1 (de) 2014-02-10 2020-10-21 Respivant Sciences GmbH Verfahren zur behandlung von lungenerkrankungen mit mastzellstabilisatoren
US20150224077A1 (en) 2014-02-10 2015-08-13 Patara Pharma, LLC Methods for the Treatment of Systemic Disorders Treatable with Mast Cell Stabilizers, including Mast Cell Related Disorders
BR112017002356A2 (pt) * 2014-08-08 2017-11-28 Shanghai Hightide Biopharmaceutical Ltd composições de formulação líquida, dispositivos de entrega de medicamento e métodos para preparação e uso dos mesmos
KR102581975B1 (ko) 2015-03-11 2023-09-25 알렉스자 파마스티칼즈, 인크. 열 에어로졸 응축 공정을 위한 에어웨이에서 대전방지 소재의 용도
GB201509820D0 (en) * 2015-05-06 2015-07-22 Nicoventures Holdings Ltd Aerosol delivery device
EP3331522A1 (de) 2015-08-07 2018-06-13 Patara Pharma LLC Verfahren zur behandlung von mastzellbedingten erkrankungen mit mastzellstabilisatoren
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
CA3035528A1 (en) 2016-08-31 2018-03-08 Respivant Sciences Gmbh Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
JP2019531308A (ja) 2016-10-07 2019-10-31 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 肺線維症の治療のためのクロモリン組成物
WO2022173689A1 (en) 2021-02-09 2022-08-18 University Of Georgia Research Foundation, Inc. Human monoclonal antibodies against pneumococcal antigens
WO2023198757A1 (en) 2022-04-14 2023-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0152446B1 (de) 1983-08-18 1988-12-21 Imperial Chemical Industries Plc Elektrostatisches zerstäubungsverfahren und vorrichtung zu dessen durchführung
GB8604328D0 (en) 1986-02-21 1986-03-26 Ici Plc Producing spray of droplets of liquid
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US6105571A (en) 1992-12-22 2000-08-22 Electrosols, Ltd. Dispensing device
GB9226717D0 (en) 1992-12-22 1993-02-17 Coffee Ronald A Induction-operated electro-hydrodynamic spray device with means of modifying droplet trajectories
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
GB9406255D0 (en) * 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB2327895B (en) 1997-08-08 2001-08-08 Electrosols Ltd A dispensing device
US6158431A (en) 1998-02-13 2000-12-12 Tsi Incorporated Portable systems and methods for delivery of therapeutic material to the pulmonary system
GB2334461B (en) * 1998-02-20 2002-01-23 Bespak Plc Inhalation apparatus
FR2776538B1 (fr) * 1998-03-27 2000-07-21 Centre Nat Rech Scient Moyens de pulverisation electrohydrodynamique
GB2345010B (en) 1998-12-17 2002-12-31 Electrosols Ltd A delivery device
US6397838B1 (en) * 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method

Also Published As

Publication number Publication date
EP1173245B1 (de) 2004-09-01
WO2000066206A3 (en) 2001-02-08
CA2370853C (en) 2007-07-10
DE60013425T2 (de) 2005-09-08
US6503481B1 (en) 2003-01-07
ATE274955T1 (de) 2004-09-15
AU4979700A (en) 2000-11-17
EP1173245A2 (de) 2002-01-23
JP2002543165A (ja) 2002-12-17
WO2000066206A2 (en) 2000-11-09
CA2370853A1 (en) 2000-11-09
MXPA01011283A (es) 2002-11-04
ES2226843T3 (es) 2005-04-01
BR0010262A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
DE60013425D1 (de) Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken
IT1318539B1 (it) Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
ATE374049T1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
TW200505402A (en) Ophthalmic drug delivery device
AR064614A1 (es) Producto combinado par controlar parasitos en animales
CO5280133A1 (es) Dispositivo y sistema para aerosolizar formulaciones farmaceuticas
AU2003279705A1 (en) Vaporiser
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
EA200301275A1 (ru) Капсулы для ингаляции
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
DK1389137T3 (da) Sammensætninger til lungelægemiddellevering af protein
TW200621268A (en) Antimicrobial copolymers and uses thereof
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
BR0109162A (pt) Viscoelásticos para uso na cirurgia do ouvido médio
BR0116168A (pt) Formulação repelente de inseto liberável por dispositivo piezelétrico
BR0210630A (pt) Sistema fornecedor de liberação prolongada
CY1110037T1 (el) Σκευασματα για βενζιμιδαζολυλ πυριδυλ αιθερες
ATE364381T1 (de) Formulierungen zur verwendung in inhalationsvorrichtungen
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
MX2009011641A (es) Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.
BR0016884A (pt) Aerossol de gota lìquida de gama-ifn e método
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
MXPA06001125A (es) Concentrado de suspension aceitosa que contiene diflufenicano.
BRPI0417763A (pt) laminados elásticos respiráveis e métodos de fabricação dos mesmos
BR9909806A (pt) Processo de moagem com energia fluida e aparelho

Legal Events

Date Code Title Description
8364 No opposition during term of opposition